Less Ads, More Data, More Tools Register for FREE

Pin to quick picksACTA.L Regulatory News (ACTA)

  • There is currently no data for ACTA

Director/PDMR Shareholding

13 Jul 2007 11:46

Acta S.p.A.13 July 2007 Acta S.p.A.13th July 2007 Acta S.p.A. (the "Company") Acta S.p.A. announces that on 12th July 2007, following the recommendation ofthe Remuneration Committee, the Board approved the following grants of optionsover the Ordinary Shares of the Company to the Directors pursuant to the 2007Share Option Scheme. These grants are all conditional upon approval byshareholders at the next shareholders meeting, to be scheduled on or around 5thSeptember 2007. Name Title Number of Total number of options options following granted grant Paolo Bert Chief Executive Officer 163,842 1,119,908Toby Woolrych Chief Operating Officer 120,917 776,631Paul Barritt Chief Financial Officer 90,687 156,987Robert Drummond Non-Executive Chairman 31,741 60,301Fabio Mastrangelo Non-Executive Director 27,206 27,206Geoff Bicknell Non-Executive Director 22,672 43,072Marco Casoni Non-Executive Director 22,672 43,072 Details of the 2007 Share Option Scheme are as follows: The exercise price of the options is 115p per share, being the price per shareof the £5.75 million subscription by Sumitomo Corporation and certaininstitutional investors as announced on 12th July 2007. Options will becomeexercisable within four years following the announcement of a six monthstatutory reporting period showing a profit ending no later than 31st December2010. If the options have not previously become exercisable, they will lapse on 31 May2011 unless the Board, upon the recommendation of the Remuneration Committee,reasonably considers that the Company has made significant progress in addingshareholder value in the relevant period, in which circumstances the Board mayeither allow the options to become exercisable or else extend the period inwhich to achieve profitability. The flexibility given to the Board is consistentwith similar provisions in the 2006 Share Option Scheme. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
27th Jul 20067:01 amRNSTrading Statement
28th Jun 200612:00 pmRNSAGM Statement
12th Jun 200610:00 amRNSAnnual Report Posted
24th May 200610:34 amRNSOperational Update
28th Apr 200612:35 pmRNSDirector dealings
24th Apr 20067:01 amRNSDirector/PDMR Shareholding
31st Mar 200610:01 amRNSNotice of Major Interest
23rd Mar 20067:03 amRNSFinal Results
6th Mar 20068:48 amRNSChange of Registered Office
23rd Feb 20067:01 amRNSNotice of Results
21st Feb 20069:54 amRNSHolding(s) in Company
19th Jan 20067:01 amRNSFiling of patent application
19th Jan 20067:01 amRNSTrading Statement
21st Nov 20057:01 amRNSUpdate on Power Output
4th Oct 20058:00 amRNSFirst Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.